Adma Biologics: 3Q Earnings Snapshot
RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Thursday reported a loss of $15.1 million in its third quarter.
On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 33 cents.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 33 cents per share.
The infectious disease drug developer posted revenue of $4.2 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $5.4 million.
Adma Biologics shares have climbed 79 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.74, more than doubling in the last 12 months.